Regulation of in vivo IgE biosynthesis in mice with complete Freund's adjuvant.
Complete Freund's adjuvant (CFA) administered before sensitization dampened the normal and cyclophosphamide-enhanced response of high and moderate IgE responder phenotype mice (CAF1 and C57B1/6J, respectively). CFA-induced suppression of IgE biosynthesis was effective in reducing anaphylactic histamine release from approximately 2,900 ng histamine per milliliter to background levels (less than 100 ng/ml). CFA-induced ascites fluid was able to reduce the cyclophosphamide-enhanced IgE response of low-responder phenotype SJL mice from 1:320 to less than 1:5 as determined by passive cutaneous anaphylaxis. Muramyl dipeptide, a mycobacterial cell wall component capable of eliciting effects similar to those seen with CFA, was shown to induce suppression of IgE production if incorporated in incomplete Freund's adjuvant. Muramyl dipeptide administered in saline was ineffective, while incomplete Freund's adjuvant alone had some immunoregulatory properties. Ongoing IgE responses were less susceptible to regulation. CFA administered to sensitized C57B1/6J mice was ineffective in inducing IgE suppression when animals were challenged with antigen.
W G
WG
Smith
G M
GM
Butchko
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000494:pharmacology; D000707:Anaphylaxis / Q000378:metabolism*; D000818:Animals; D005620:Freund's Adjuvant / Q000276:immunology* / Q000494:pharmacology; D006636:Histamine Release; D007108:Immune Tolerance / Q000187:drug effects; D007073:Immunoglobulin E / Q000096:biosynthesis*; D051379:Mice; D008815:Mice, Inbred Strains
D007073:Immunoglobulin E; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D005620:Freund's Adjuvant